Literature DB >> 15856472

Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.

Hassan Ashktorab1, Duane T Smoot, Haleh Farzanmehr, Marie Fidelia-Lambert, Bahram Momen, Linda Hylind, Christine Iacosozio-Dononue, John M Carethers, Ajay Goel, C Richard Boland, Francis M Giardiello.   

Abstract

African Americans (AAs) have a 1.5 times higher risk of colorectal carcinoma (CRC) than Caucasians. Gene silencing through CpG island hypermethylation has been associated with the genesis or progression of microsatellite instability (MSI) largely due to 1 target for hypermethylation being the DNA mismatch repair gene hMLH1; there is anecdotal evidence of an increased incidence of MSI among AAs. P16 and hMLH1 can be inactivated by hypermethylation of their respective promoter regions, abrogating the ability to regulate cell proliferation and repair processes. We studied such methylation, as well as hMHS2 expression in colorectal cancers from AA patients to determine if MSI is associated with epigenetic silencing. Experiments were conducted on matched normal and colon cancer tissues from AA patients (n = 51). A total of 5 microsatellite markers (D2S123, D5S346, D17S250, BAT25 and BAT26) were used to evaluate MSI status. P16 and hMLH1 promoter methylation status was determined following bisulfite modification of DNA and using methylation specific PCR, while immunohistochemistry (IHC) was used to examine expression of hMLH1 and hMSH2. A total of 22 (43%) cancers demonstrated microsatellite instability-high (MSI-H), while 27 were microsatellite stable (MSS) and 2 were microsatellite instability-low (MSH-L). Most of the MSI-H tumors were proximal, well differentiated and highly mucinous. Most patients in the MSI-H group were females (68%). The p16 promoter was methylated in 19 of 47 (40%) tumors. A total of 7 of these CRCs demonstrated MSI-H (33%). The hMLH1 promoter was methylated in 29 of 34 (85%) tumors, of which 13 CRCs demonstrated MSI-H (87%). hMLH1 and hMSH2 staining was observed in 66% and 38% of MSI-H tumors, respectively. Overall, the prevalence of MSI-H colorectal tumor was 2-3-fold higher, while the defect in the percentage expression of mismatch repair (MMR) genes (hMLH1 and hMSH2) was similar in AA patients compared to the U.S. Caucasian population. Similar numbers of AA MSS tumors with p16 and hMLH1 methylation likely indicate hemimethylation of genes that might reflect environmental or genetic influences that might be more common in the AA population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856472      PMCID: PMC4155490          DOI: 10.1002/ijc.21062

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status.

Authors:  S Marcella; J E Miller
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

2.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Racial and ethnic factors in the genetic pathogenesis of colorectal cancer.

Authors:  J M Carethers
Journal:  J Assoc Acad Minor Phys       Date:  1999

4.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

5.  Does menthol attenuate the effect of bupropion among African American smokers?

Authors:  Kolawole S Okuyemi; Jasjit S Ahluwalia; Maiko Ebersole-Robinson; Delwyn Catley; Matthew S Mayo; Ken Resnicow
Journal:  Addiction       Date:  2003-10       Impact factor: 6.526

6.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 7.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

Review 8.  Gender and colorectal cancer.

Authors:  J J DeCosse; S S Ngoi; J S Jacobson; W J Cennerazzo
Journal:  Eur J Cancer Prev       Date:  1993-03       Impact factor: 2.497

9.  Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.

Authors:  Cheryl L Wright; Ian D Stewart
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

10.  Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

Authors:  J M Cunningham; E R Christensen; D J Tester; C Y Kim; P C Roche; L J Burgart; S N Thibodeau
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

View more
  38 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Authors:  Kristin Wallace; Maria V Grau; Dennis Ahnen; Dale C Snover; Douglas J Robertson; Daus Mahnke; Jiang Gui; Elizabeth L Barry; Robert W Summers; Gail McKeown-Eyssen; Robert W Haile; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

3.  Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.

Authors:  Terry Hyslop; David S Weinberg; Stephanie Schulz; Alan Barkun; Scott A Waldman
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

4.  Microsatellite instability and promoter hypermethylation in colorectal cancer in India.

Authors:  V V Ravi Kanth; Sandeep Bhalsing; M Sasikala; G V Rao; R Pradeep; Urmila Steffie Avanthi; D Nageshwar Reddy
Journal:  Tumour Biol       Date:  2014-01-10

5.  Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.

Authors:  Muneer J Al-Husseini; Anas M Saad; Khalid A Jazieh; Abdelmagid M Elmatboly; Ahmad Rachid; Mohamed M Gad; Inas A Ruhban; Talal Hilal
Journal:  Int J Colorectal Dis       Date:  2018-11-15       Impact factor: 2.571

6.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

7.  A black-white comparison of the quality of stage-specific colon cancer treatment.

Authors:  Jamillah Berry; Lee Caplan; Sharon Davis; Patrick Minor; Margaret Counts-Spriggs; Roni Glover; Vickie Ogunlade; Kevin Bumpers; John Kauh; Otis W Brawley; Christopher Flowers
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

8.  Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma.

Authors:  Hassan Ashktorab; Kevin Belgrave; Fatemeh Hosseinkhah; Hassan Brim; Mehdi Nouraie; Mikiko Takkikto; Steve Hewitt; Edward L Lee; R H Dashwood; Duane Smoot
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

9.  Distinct genetic alterations in colorectal cancer.

Authors:  Hassan Ashktorab; Alejandro A Schäffer; Mohammad Daremipouran; Duane T Smoot; Edward Lee; Hassan Brim
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

10.  Distinct high-profile methylated genes in colorectal cancer.

Authors:  Pooneh Mokarram; Krishan Kumar; Hassan Brim; Fakhraddin Naghibalhossaini; Mehdi Saberi-firoozi; Mehdi Nouraie; Robert Green; Ed Lee; Duane T Smoot; Hassan Ashktorab
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.